Catherine Prescott
Director/Board Member bei SKINBIOTHERAPEUTICS PLC
Vermögen: 19 104 $ am 31.03.2024
Profil
Catherine Denise Prescott is the founder of CellCentric Ltd.
which was founded in 2004.
She is also the founder of Biolatris Ltd.
and Quartet Innovation Partners Ltd.
Dr. Prescott's current jobs include Chairman at TrakCel Ltd.
and Non-Executive Director at SkinBioTherapeutics Plc since 2017.
Dr. Prescott's former jobs include Science Director at Avlar Ltd., Non-Executive Director at Videregen Ltd., Senior Associate at the University of Cambridge, Member at The Babraham Institute, and Trustee at IMET2000.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
SKINBIOTHERAPEUTICS PLC
0,06% | 30.06.2023 | 118 612 ( 0,06% ) | 19 104 $ | 31.03.2024 |
Aktive Positionen von Catherine Prescott
Unternehmen | Position | Beginn |
---|---|---|
SKINBIOTHERAPEUTICS PLC | Director/Board Member | 01.03.2017 |
TrakCel Ltd.
TrakCel Ltd. Packaged SoftwareTechnology Services TrakCel Ltd. delivers a suite of integrated technologies to orchestrate the cell therapy supply chain for autologous and allogeneic therapies. The firm serves to medical centers, distribution and logistics clients, manufacturers, and therapy owners and trial sponsors/license holders. The company was founded in 2012 and is headquartered in Cardiff, the United Kingdom. | Chairman | - |
Ehemalige bekannte Positionen von Catherine Prescott
Unternehmen | Position | Ende |
---|---|---|
Avlar Ltd.
Avlar Ltd. Investment ManagersFinance Avlar Ltd. (Avlar BioVentures) is a venture capital firm founded in 1999 by Alan Goodman and Daniel Roach. The firm is headquartered in Cambridge, United Kingdom. | Director of Investments | 30.06.2007 |
University of Cambridge | Corporate Officer/Principal | - |
The Babraham Institute
The Babraham Institute Miscellaneous Commercial ServicesCommercial Services Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB. | Corporate Officer/Principal | - |
IMET2000 | Director/Board Member | - |
Quartet Innovation Partners Ltd. | Founder | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SKINBIOTHERAPEUTICS PLC | Health Technology |
Private Unternehmen | 8 |
---|---|
Avlar Ltd.
Avlar Ltd. Investment ManagersFinance Avlar Ltd. (Avlar BioVentures) is a venture capital firm founded in 1999 by Alan Goodman and Daniel Roach. The firm is headquartered in Cambridge, United Kingdom. | Finance |
CellCentric Ltd.
CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
The Babraham Institute
The Babraham Institute Miscellaneous Commercial ServicesCommercial Services Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB. | Commercial Services |
IMET2000 | |
Videregen Ltd.
Videregen Ltd. BiotechnologyHealth Technology Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom. | Health Technology |
Biolatris Ltd. | |
Quartet Innovation Partners Ltd. | |
TrakCel Ltd.
TrakCel Ltd. Packaged SoftwareTechnology Services TrakCel Ltd. delivers a suite of integrated technologies to orchestrate the cell therapy supply chain for autologous and allogeneic therapies. The firm serves to medical centers, distribution and logistics clients, manufacturers, and therapy owners and trial sponsors/license holders. The company was founded in 2012 and is headquartered in Cardiff, the United Kingdom. | Technology Services |